Diego Caprioglio

Diego Caprioglio is an Associate Professor in the Department of Pharmaceutical Sciences at the University of Eastern Piedmont Amedeo Avogadro. His research focuses on cannabinoid chemistry, phytocannabinoids, and their bioactivity, with applications in medicinal chemistry and drug discovery. He has contributed to studies on Alzheimer’s disease treatments, cancer therapeutics, and fluorescent probes for precision surgery.

Key research interests include cannabinoid synthesis, natural product characterization, and the development of bioactive compounds targeting neurodegenerative and oncological disorders. His work spans from synthetic methodologies to in vivo/in vitro testing, with a strong emphasis on translational medicine.

Notable projects include the development of fluorescent probes targeting gliomas and studies on cannabidiolic acids as enzyme inhibitors. He collaborates on initiatives funded by the Italian Ministry of Health, such as the 2023–2025 project on cancer stem cells and oncosurgery tools.

His publications highlight advancements in cannabinoid pharmacology, including Δ8-THC’s neuroprotective effects and curcumin-based theranostics. He has also explored minor cannabinoids’ biomedical potential and optimized synthetic pathways for complex natural products like ophiopogonol.